Skip to content
healthcare.dev

Irinotecan hydrochloride

NDC 16714-027, Irinotecan hydrochloride, injection, from Northstar Rx LLC.

Product NDC
16714-027
Status
Listed
Labeler
Northstar Rx LLC
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212993
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16714-027 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IRINOTECAN HYDROCHLORIDE20 mg/mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
16714-027-01167140027011 VIAL, SINGLE-DOSE in 1 CARTON (16714-027-01) / 2 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4f98e9ed-f7b1-5346-af72-fccb0abf3f4b
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=16714-027

Use it

Look up 16714-027 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16714-027 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16714-027. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.